Invention Grant
- Patent Title: Chimeric IL-1 receptor type I antagonists
- Patent Title (中): 嵌合IL-1受体I型拮抗剂
-
Application No.: US13812582Application Date: 2011-07-29
-
Publication No.: US08853150B2Publication Date: 2014-10-07
- Inventor: Thomas M. Barnes , Jinzhao Hou , Bracken M. King
- Applicant: Thomas M. Barnes , Jinzhao Hou , Bracken M. King
- Applicant Address: US MA Cambridge
- Assignee: Eleven Biotherapeutics, Inc.
- Current Assignee: Eleven Biotherapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Lando & Anastasi LLP
- International Application: PCT/US2011/045995 WO 20110729
- International Announcement: WO2012/016203 WO 20120202
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K14/715 ; C07K14/545 ; A61K38/00

Abstract:
Featured herein are non-naturally occurring cytokine domains that can be used, inter alia, to modulate cellular signalling responsive to interleukin-1 receptor I (IL-1 RI), to treat disorders, and to detect and/or bind to cellular receptors, as well as other agents. Exemplary cytokine domains can contain amino acid residues from at least two parental cytokines domains, for example, receptor binding features, surface features, β strands, and loops from at least two parental cytokines domains.
Public/Granted literature
- US20130209396A1 CHIMERIC IL-1 RECEPTOR TYPE I AGONISTS AND ANTAGONISTS Public/Granted day:2013-08-15
Information query
IPC分类: